Opioid-Related Disparities in Sexual Minority Youth, 2017.
Opioid-Related Disparities in Sexual Minority Youth, 2017.
复制标题
DOI：
10.1097/adm.0000000000000628
复制
发表时间：
2020-12
影响因子：
5.5
通讯作者：
Mair CF
中科院分区：
文献类型：
--
作者：
Wilson JD;Sumetsky NM;Coulter RWS;Liebschutz J;Miller E;Mair CF
鉴于阿片类药物的流行，必须了解哪些青年亚群使用阿片类药物的风险较高。与异性恋青年相比，性少数群体的药物使用率有所增加。我们的研究旨在检查青少年处方阿片类药物滥用和海洛因使用的患病率。然后，我们检查了处方阿片类药物滥用和海洛因使用调整常见协变量的几率。使用2017年青年风险行为监测系统数据，我们研究了性少数青年中处方阿片类药物滥用和海洛因使用的终身几率，这些青少年由性身份和性行为定义。我们使用logistic回归调整年龄，性别和种族。28.5%的男同性恋/女同性恋和25.1%的双性恋青年报告滥用，而异性恋青年为12.5%。近十分之一的男同性恋/女同性恋青年报告有海洛因使用史，而双性恋青年和异性恋青年的比例分别为4.1%和1.1%。在报告有性接触史的受试者中，与仅有异性接触史的受试者相比，有同性接触和与两性有性接触的受试者终生使用海洛因的几率较高（aOR：3.77; 95% CI：1.68，8.44和aOR：7.44; 95% CI：4.59，12.06）。我们证明了初步证据，性少数青年有显着的阿片类药物相关的健康差异，终生处方阿片类药物滥用和海洛因使用的可能性更大。由于早期接触阿片类药物与发展阿片类药物使用障碍的风险增加以及阿片类药物发病率和死亡率增加有关，因此提供者必须认识到性少数青年的独特需求并将其纳入传统的治疗和预防模式。
In light of the opioid epidemic, it is essential to understand which subgroups of youth are at elevated risk for opioid use. Sexual minority groups have increased rates of substance use compared to heterosexual youth. Our study aims to examine the prevalence of both prescription opioid misuse and heroin use in adolescents. We then examine odds of prescription opioid misuse and heroin use adjusting for common covariates. Using 2017 Youth Risk Behavior Surveillance System data, we examined lifetime odds of prescription opioid misuse and heroin use among sexual minority youth as defined by sexual identity and sexual behavior. We used logistic regression adjusting for age, sex, and race. 28.5% of gay/lesbian and 25.1% of bisexual youth reported misuse compared to 12.5% of heterosexual youth. Nearly one in ten gay/lesbian youth reported a history of heroin use compared to 4.1% of bisexual and 1.1% of heterosexual young people. Among those who reported having a history of sexual contact, those with same sex contact and sexual contact with both sexes had elevated odds of lifetime heroin use compared to those with a history of opposite sex contact only (aOR: 3.77; 95% CI: 1.68, 8.44 and aOR: 7.44; 95% CI: 4.59, 12.06 respectively). We demonstrated preliminary evidence sexual minority youth have significant opioid-related health disparities with greater odds of lifetime prescription opioid misuse and heroin use. As early exposure to opioids is associated with greater risk for developing an opioid use disorder and increased opioid-morbidity and mortality, it is critical that providers recognize and incorporate the unique needs for sexual minority youth into traditional treatment and prevention models.